Gut bacteria require neutrophils to promote mammary tumorigenesis
Name
Lakritz_3328-46347-3-PB.pdf
Size
1.62 MB
Format
Adobe PDF
Checksum (MD5)
60f57ee3a73220b18c4fc12c238209a9
Author(s) • • • • • • • • •
Lakritz, Jessica
Poutahidis, Theofilos
Mirabal, Sheyla
Varian, Bernard
Levkovich, Tatiana
Ibrahim, Yassin
Ward, Jerrold M.
Teng, Ellen C.
Fisher, Brett
Parry, Nicola
Date Issued
March 2015
Journal
Oncotarget
Publisher
Impact Journals/National Center for Biotechnology Information (U.S.)
Citation
Lakritz, Jessica R., et al. "Gut bacteria require neutrophils to promote mammary tumorigenesis." Oncotarget, Vol. 6, No. 11 (2015). © 2015 Impact Journals, LLC.
Version
Final published version
Abstract
Recent studies suggest that gastrointestinal tract microbiota modulate cancer development in distant non-intestinal tissues. Here we tested mechanistic hypotheses using a targeted pathogenic gut microbial infection animal model with a predilection to breast cancer. FVB-Tg(C3-1-TAg)cJeg/JegJ female mice were infected by gastric gavage with Helicobacter hepaticus at three-months-of-age putting them at increased risk for mammary tumor development. Tumorigenesis was multifocal and characterized by extensive infiltrates of myeloperoxidase-positive neutrophils otherwise implicated in cancer progression in humans and animal models. To test whether neutrophils were important in etiopathogenesis in this bacteria-triggered model system, we next systemically depleted mice of neutrophils using thrice weekly intraperitoneal injections with anti-Ly-6G antibody. We found that antibody depletion entirely inhibited tumor development in this H. hepaticus-infected model. These data demonstrate that host neutrophil-associated immune responses to intestinal tract microbes significantly impact cancer progression in distal tissues such as mammary glands, and identify gut microbes as novel targets for extra-intestinal cancer therapy.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Division of Comparative Medicine
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=3328